IMO, PP is Denners lapdog, Denner is calling the shots.
Denner has had nearly a year to think about what he'd do day 1. The pp is gone, to no effect.
Anything Denner does beyond window dressing with '113 and '788 kills any hope of maximized partnering or b/o potential. He can cut expenses/ worthless trials/headcount, but the franchises are off limits.
wilco, you are around enough to remember Ariad's best day in 2012 was before Pona was approved. Downhill from there. I can't think of a GOOD reason not to have released '113 data in 2015 as promised. Or filing the '788 IND. What could the strategy be? OR is there bad news? At least '113 data has been rescheduled to Feb 2, submission of ASCO Abstracts. Not a peep on the '788 IND. And that delay, delays everything '788 trial start, day-by-day.
You can turn off your computer and ignore warning signs. I remember ignoring warning signs before the crash. It's bad advice, IMO, on Ariad.
Market Data 
Markets 
AI
